Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxychloroquine Administration for Reduction of Pexophagy

NCT03856866 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT03856866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03856866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxychloroquine Administration for Reduction of Pexophagy
Lead sponsor
The Hospital for Sick Children
Phase
Phase 2
Overall status
Completed
Start date
January 11, 2019
Completion date
May 5, 2020
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peroxisome biogenesis disorders, zellweger syndrome